Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Operations

v3.20.4
Consolidated Statements of Operations - USD ($)
12 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Income Statement [Abstract]    
Revenues
Operating Expenses:    
Research and development 8,812,810 8,596,898
General and administrative 8,094,614 6,285,480
Stock-based compensation - general and administrative 803,261 715,983
Total Operating Expenses 17,710,685 15,598,361
Operating Loss (17,710,685) (15,598,361)
Other Income (Expense):    
Interest income 68,066 52,660
Other income 110,207
Interest expense (15,673) (16,443)
Total Other Income, Net 162,600 36,217
Loss before Income Taxes (17,548,085) (15,562,144)
Income tax benefit
Net Loss $ (17,548,085) $ (15,562,144)
Net Loss Per Share - Basic and Diluted $ (0.45) $ (0.77)
Weighted Average Common Shares Outstanding    
Basic and diluted 39,165,248 20,161,854